Life Expectancy in Frail Individuals
Frailty-Specific Life Expectancy Estimates
- Frail older adults have a life expectancy of less than 1 year remaining, with severely frail individuals approaching end-of-life and unable to recover even from minor illness, as noted by the British Journal of Pharmacology and European Heart Journal 1, 2, 3
- Completely dependent frail individuals (CFS 7) have a life expectancy typically not at high risk of dying within 6 months, according to the Journal of the American College of Cardiology and European Heart Journal 4, 3
- However, deprescribing guidelines categorize these patients as having less than 1 year of life remaining, as stated by the British Journal of Pharmacology 1, 2
- Completely dependent and very severely frail individuals (CFS 8) are approaching end of life, as indicated by the Journal of the American College of Cardiology and European Heart Journal 4, 3
- Very severely frail individuals could not recover even from a minor illness, indicating imminent mortality risk, as reported by the Journal of the American College of Cardiology and European Heart Journal 4, 3
- Terminally ill individuals (CFS 9) have a life expectancy of less than 6 months, as noted by the Journal of the American College of Cardiology and European Heart Journal 4, 3
Mortality Risk by Frailty Severity
- Each 0.1 increment in frailty index increases hazard ratios for both cardiovascular and non-cardiovascular mortality, as found by Nature Aging 5, 6
- Mortality becomes high when frailty index score approaches 0.7, according to Nature Aging 6
Critical Clinical Context
- A common pitfall is assuming all "frail" labels indicate the same prognosis, as warned by Nature Aging 7, 8, 9
- Frailty is potentially reversible through interventions targeting physical activity, nutrition, and deficit accumulation, as suggested by the American College of Cardiology and European Heart Journal 10
- For medication management decisions, guidelines reference frail older adults with less than 1 year of life remaining, as established by the British Journal of Pharmacology 1, 2